Laquinimod
Laquinimod is an orally administered neuroimmunomodulator initially developed for the treatment of multiple sclerosis.
| Trivial name | ABR-215062; LAQ |
| Catalog Number | CSN10659 |
| Alternative Name(s) | ABR-215062; LAQ |
| Research Area | Immunology/Inflammation |
| Molecular Formula | C19H17ClN2O3 |
| CAS# | 248281-84-7 |
| Purity | ≥98% |
| SMILES | C1=CC=C(Cl)C2=C1N(C(=C(C2=O)C(=O)N(CC)C3=CC=CC=C3)O)C |
| Size | 5mg |
| Supplier Page | https://www.csnpharm.com/products/laquinimod.html |